Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03084406 · ClinicalTrials.gov registry record · NA
Efficacy of Centervention-ATOD: An Implementation Tool for Dissemination of Evidence-based Programs for Substance Abuse
A NA study, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- NA
- Development phase
- 327
- Enrollment target
NCT03084406 is a NA study that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 327 participants.
The verdict
NCT03084406, a NA study, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 327 participants
- Enrollment target
Study Summary
The pilot test of Centervention-ATOD, a customizable suite of online tools specifically designed to support quality implementation and sustainability of any ATOD-EBP within real-world service settings, will evaluate whether the product awards additive benefits in provider implementation proficiency and efficacy, quality of implementation delivery, and EBP (i.e., Free Talk or CHOICE) outcomes compared to traditional implementation methods. Additionally, a cost-effectiveness study will be conducted to assess whether the implementation support strategy (i.e., Centervention-ATOD) is more cost-effective than traditional implementation methods.
Interventions
- OTHER Centervention-ATOD (CV-ATOD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2017-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03084406
The ClinicalTrials.gov registry entry for NCT03084406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 327 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 3-C Institute for Social Development, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Centervention-ATOD (CV-ATOD) is the first listed.
NCT03084406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03084406 about?
NCT03084406 is a clinical study titled "Efficacy of Centervention-ATOD: An Implementation Tool for Dissemination of Evidence-based Programs for Substance Abuse". The pilot test of Centervention-ATOD, a customizable suite of online tools specifically designed to support quality implementation and sustainability of any ATOD-EBP within real-world service settings, will evaluate whether the product awards additive benefits in provider implementation proficiency ...
What is the current status of trial NCT03084406?
This trial is currently completed. It is a NA study. The enrollment target is 327 participants. The study started on 2017-02-13. Estimated completion is 2017-12-22.
What interventions are being tested in trial NCT03084406?
The interventions under investigation include: Centervention-ATOD (CV-ATOD) (OTHER).
Who is sponsoring clinical trial NCT03084406?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.